[go: up one dir, main page]

DK1513532T3 - Bortskaffelsessystemer til transdermale administrationsanordninger for at hindre misbrug af de aktive stoffer, der er indeholdt deri - Google Patents

Bortskaffelsessystemer til transdermale administrationsanordninger for at hindre misbrug af de aktive stoffer, der er indeholdt deri

Info

Publication number
DK1513532T3
DK1513532T3 DK03757468T DK03757468T DK1513532T3 DK 1513532 T3 DK1513532 T3 DK 1513532T3 DK 03757468 T DK03757468 T DK 03757468T DK 03757468 T DK03757468 T DK 03757468T DK 1513532 T3 DK1513532 T3 DK 1513532T3
Authority
DK
Denmark
Prior art keywords
delivery device
transdermal delivery
active component
contained
active substances
Prior art date
Application number
DK03757468T
Other languages
English (en)
Inventor
Carl J Baker
Ihor Shevchuk
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1513532T3 publication Critical patent/DK1513532T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
    • B09B3/0075—Disposal of medical waste
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B2101/00—Type of solid waste
    • B09B2101/65—Medical waste
    • B09B2101/68—Transdermal patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Environmental & Geological Engineering (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Processing Of Solid Wastes (AREA)
  • Adhesives Or Adhesive Processes (AREA)
DK03757468T 2002-06-10 2003-06-10 Bortskaffelsessystemer til transdermale administrationsanordninger for at hindre misbrug af de aktive stoffer, der er indeholdt deri DK1513532T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38780002P 2002-06-10 2002-06-10
PCT/US2003/018256 WO2003103673A1 (en) 2002-06-10 2003-06-10 Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein

Publications (1)

Publication Number Publication Date
DK1513532T3 true DK1513532T3 (da) 2007-07-02

Family

ID=29736367

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03757468T DK1513532T3 (da) 2002-06-10 2003-06-10 Bortskaffelsessystemer til transdermale administrationsanordninger for at hindre misbrug af de aktive stoffer, der er indeholdt deri

Country Status (22)

Country Link
US (2) US20040033255A1 (da)
EP (4) EP2298302A1 (da)
JP (3) JP4949625B2 (da)
KR (2) KR101407131B1 (da)
CN (2) CN100525767C (da)
AT (1) ATE355061T1 (da)
AU (2) AU2003251482A1 (da)
CA (1) CA2488915C (da)
CY (1) CY1107630T1 (da)
DE (1) DE60312160T2 (da)
DK (1) DK1513532T3 (da)
EA (1) EA007240B1 (da)
ES (1) ES2283812T3 (da)
IL (1) IL165517A0 (da)
MX (1) MXPA04012333A (da)
NO (1) NO334455B1 (da)
NZ (1) NZ537180A (da)
PT (1) PT1513532E (da)
SI (1) SI1513532T1 (da)
UA (1) UA82194C2 (da)
WO (1) WO2003103673A1 (da)
ZA (1) ZA200409495B (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
EA009623B1 (ru) * 2003-04-30 2008-02-28 Пэдью Фарма Л.П. Устойчивая к манипуляциям дозировочная форма для трансдермального введения
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
US8535711B2 (en) * 2004-01-23 2013-09-17 Teikoku Pharma Usa, Inc. Medication disposal system
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
HUE030128T2 (en) * 2004-02-23 2017-04-28 Euro Celtique Sa Anti-abuse device for transdermal opioid administration
US20060045897A1 (en) * 2004-08-27 2006-03-02 Aso Corporation Occlusive articles for wart treatment
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
WO2006069008A1 (en) * 2004-12-22 2006-06-29 Vesta Medical, Llc Compositions and devices for inactivation of pharmaceuticals to facilitate waste disposal, and methods thereof
US20070014839A1 (en) * 2005-07-18 2007-01-18 Stefan Bracht Decomposer film for transdermal patches
AU2006326377B2 (en) * 2005-12-13 2010-10-07 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
DK2054031T3 (da) 2006-07-21 2016-05-17 Biodelivery Sciences Int Inc Transmukosale indgivelsesindretninger med forbedret optagelse
US20080226702A1 (en) * 2007-03-16 2008-09-18 Endo Pharmaceuticals, Inc. Transdermal Delivery Form Disposal Systems and Methods
US9700552B2 (en) 2008-02-28 2017-07-11 Syntropharma Limited Pharmaceutical compositions for treatment of addiction
WO2009120889A2 (en) * 2008-03-26 2009-10-01 Alltranz Inc. Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
DE202008004785U1 (de) * 2008-04-04 2009-08-13 Grünenthal GmbH Entsorgungsvorrichtung
US8329210B2 (en) * 2008-09-23 2012-12-11 Pharmapatch, Llc Twin transdermal drug delivery patch
TWI630208B (zh) 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
US8507182B2 (en) * 2009-06-09 2013-08-13 Eastman Kodak Company Method of providing lithographic printing plates
DE102009036485B4 (de) * 2009-08-07 2012-10-04 Lts Lohmann Therapie-Systeme Ag Mittel zur zerstörenden Entsorgung von medizinischen Wirkstoffen in transdermalen therapeutischen Systemen
JP2013523092A (ja) 2010-03-26 2013-06-17 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 非喫煙用タバコ製品の消費中の感覚刺激の抑制
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
EA033256B1 (ru) 2011-08-18 2019-09-30 Байоделивери Сайенсиз Интернэшнл, Инк. Не вызывающие зависимость двухслойные устройства для трансмукозальной доставки бупренорфина
JP5964435B2 (ja) * 2011-09-30 2016-08-03 テイコク ファーマ ユーエスエー インコーポレーテッド 経皮パッチ廃棄システム
BR112014005543A2 (pt) 2011-09-30 2017-03-21 Teikoku Pharma Usa Inc sistema de descarte de medicação geral
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
JP6980533B2 (ja) 2015-02-19 2021-12-15 キャンデサント・バイオメディカル・インコーポレイテッドCandesant Biomedical, Inc. 熱を発生させるための医療用デバイスおよびこれを用いた治療方法
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
GB201520390D0 (en) * 2015-11-19 2016-01-06 Euro Celtique Sa Composition
US20170273974A1 (en) 2016-03-24 2017-09-28 Medrx Co., Ltd Patch preparations with misuse prevention features
ES2957234T3 (es) 2016-03-24 2024-01-15 Medrx Co Ltd Preparación de parche con características de prevención del uso incorrecto de sustancias
US10532385B2 (en) * 2016-06-29 2020-01-14 Disposerx, Inc. Disposal of medicaments
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
CN110913912A (zh) 2017-09-22 2020-03-24 株式会社医药处方 不可再贴的贴剂
US11389844B2 (en) 2018-03-20 2022-07-19 Verde Environmental Technologies, Inc. Blister pack disposal system
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
CA3160895A1 (en) 2019-12-10 2021-06-17 Niquette Hunt Medical devices for generating heat and methods of treatment using the same
CA3160874A1 (en) * 2019-12-10 2021-06-17 Niquette Hunt Methods and systems for disposing alkali metal patches

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527864A (en) 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3540580A (en) * 1967-07-03 1970-11-17 Borden Inc Heat-seal adhesive and package
US3472931A (en) 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
US3903256A (en) 1972-02-07 1975-09-02 Procter & Gamble Compositions for topical application of animal tissue and method of enhancing penetration thereof
US3896238A (en) 1972-04-05 1975-07-22 Procter & Gamble Dermatological compositions
US3952099A (en) 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US4046886A (en) 1975-01-17 1977-09-06 The Procter & Gamble Company Dermatological compositions
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4130667A (en) 1976-01-12 1978-12-19 The Procter & Gamble Company Dermatological compositions
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4335115A (en) 1976-11-01 1982-06-15 The Procter & Gamble Company Anti-acne composition
US4166058A (en) * 1978-08-11 1979-08-28 The Goodyear Tire & Rubber Company Heat sensitive primer exhibiting color change and containing a resin blend, elemental sulfur, and a dye
US4326566A (en) 1979-09-11 1982-04-27 N. V. Weefautomaten Picanol Color selector
US4299826A (en) 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US4248748A (en) * 1980-02-04 1981-02-03 Minnesota Mining And Manufacturing Company Heat-activated adhesive
DE3047635A1 (de) * 1980-12-17 1982-07-22 Hilti AG, 9494 Schaan Klebeverfahren mittels schmelzklebstoff sowie mittel zur durchfuehrung des verfahrens
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4343798A (en) 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US4560553A (en) 1981-07-07 1985-12-24 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4510621A (en) * 1983-06-30 1985-04-09 Arvey Corporation Self-sealing pouch for forming adhesive-to-adhesive seal
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
JPS61103840A (ja) 1984-10-26 1986-05-22 Nitto Electric Ind Co Ltd 外皮投与用組成物
US4806341A (en) 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5066648A (en) 1985-11-29 1991-11-19 Merck & Co., Inc. Pyroglutamic acid esters used as dermal penetration enhancers for drugs
US4973968A (en) 1986-03-07 1990-11-27 Plessey Overseas Limited Radar system for determining first time around targets from multiple time around targets
US4863970A (en) 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4940586A (en) 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4746515A (en) 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
US4879275A (en) 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
US5225473A (en) * 1987-11-25 1993-07-06 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesives
GB8811669D0 (en) * 1988-05-17 1988-06-22 Alcan Int Ltd Colour-changeable adhesive
US5164406A (en) 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
US5641504A (en) 1988-06-09 1997-06-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolinoleate
US5378730A (en) 1988-06-09 1995-01-03 Alza Corporation Permeation enhancer comprising ethanol and monoglycerides
US4960771A (en) 1988-07-12 1990-10-02 Rajadhyaksha Vithal J Oxazolidinone penetration enhancing compounds
US5236714A (en) 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5750134A (en) 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
US5240711A (en) 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
US5069909A (en) 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
JP3196851B2 (ja) * 1991-04-01 2001-08-06 積水化学工業株式会社 医療用貼付剤
US5227169A (en) 1991-05-17 1993-07-13 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5308887A (en) * 1991-05-23 1994-05-03 Minnesota Mining & Manufacturing Company Pressure-sensitive adhesives
US5149538A (en) 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5981666A (en) * 1991-07-12 1999-11-09 Adhesives Research, Inc. Method for the production of a high performance pressure sensitive adhesive
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
US5238933A (en) 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
US5229130A (en) 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
CA2097163C (en) 1992-06-01 2002-07-30 Marianna Foldvari Topical patch for liposomal drug delivery system
US5308625A (en) 1992-09-02 1994-05-03 Cygnus Therapeutic Systems Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
US6162456A (en) 1992-09-24 2000-12-19 Ortho-Mcneil Pharmaceutical, Inc. Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
JPH0710742Y2 (ja) * 1993-02-05 1995-03-15 日本臓器製薬株式会社 救急絆創膏
EP0813865B1 (de) * 1993-04-20 2001-09-19 Hexal Ag Wirkstoffpflaster
US5520385A (en) * 1993-07-30 1996-05-28 Composite Development Corporation Article assembled with thermoreponsive material and method
AU679793B2 (en) 1993-09-29 1997-07-10 Alza Corporation Monoglyceride/lactate ester permeation enhancer
US5470529A (en) * 1994-03-08 1995-11-28 Sumitomo Metal Industries, Ltd. High tensile strength steel sheet having improved formability
US5420106A (en) 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
JP2819236B2 (ja) * 1994-05-06 1998-10-30 日東電工株式会社 経皮吸収製剤
US5540934A (en) 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
GB9425783D0 (en) * 1994-12-21 1995-02-22 Ethical Pharma Ltd Packaging of patches
US5573778A (en) * 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
US5882676A (en) 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
EP0752421B1 (en) 1995-07-07 2005-10-12 AstraZeneca AB Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists
WO1997004835A1 (de) * 1995-07-28 1997-02-13 Novartis Ag Transdermales system
US5902603A (en) 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
US5837289A (en) 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
ES2191834T3 (es) 1996-10-24 2003-09-16 Alza Corp Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos.
EP0942697A1 (en) 1996-10-30 1999-09-22 THERATECH, INC. (a Delaware Corporation) Fatty acid esters of lactic acid salts as permeation enhancers
DE19649534B4 (de) * 1996-11-29 2004-05-06 Lts Lohmann Therapie-Systeme Ag Verpackung aus Verbundpackstoff zum Verpacken von wirkstoffhaltigen Pflastern
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5804215A (en) * 1997-03-21 1998-09-08 L. Perrigo Company Transdermal patch disposal system and method
US6017983A (en) * 1998-01-29 2000-01-25 Alpha Metals, Inc. Color indicator for completion of polymerization for thermosets
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
US7018649B2 (en) * 2000-10-23 2006-03-28 Euro-Celtique, S.A. Felodipine transdermal device and methods
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
EP2113315B1 (en) * 2001-04-23 2014-05-21 Euro-Celtique S.A. Disposal system for transdermal dosage form
ES2377672T3 (es) * 2001-05-01 2012-03-29 Euro-Celtique S.A. Sistemas transdérmicos resistentes al abuso que contienen opioides
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain

Also Published As

Publication number Publication date
EP2266565A1 (en) 2010-12-29
ES2283812T3 (es) 2007-11-01
DE60312160T2 (de) 2007-10-31
DE60312160D1 (de) 2007-04-12
CY1107630T1 (el) 2013-04-18
AU2009217420A1 (en) 2009-10-15
EA200401564A1 (ru) 2005-08-25
EP1513532A1 (en) 2005-03-16
JP5898242B2 (ja) 2016-04-06
KR101407131B1 (ko) 2014-06-19
US20040033255A1 (en) 2004-02-19
AU2009217420B2 (en) 2013-06-13
JP2011016802A (ja) 2011-01-27
JP4949625B2 (ja) 2012-06-13
EP1513532B1 (en) 2007-02-28
EP1837023A1 (en) 2007-09-26
CA2488915A1 (en) 2003-12-18
NO20050126L (no) 2005-01-10
NO334455B1 (no) 2014-03-10
US20080274168A1 (en) 2008-11-06
ZA200409495B (en) 2006-05-31
JP2005538058A (ja) 2005-12-15
KR20110120358A (ko) 2011-11-03
CN100525767C (zh) 2009-08-12
KR20050020977A (ko) 2005-03-04
EA007240B1 (ru) 2006-08-25
JP5507367B2 (ja) 2014-05-28
CN101455649B (zh) 2014-02-26
PT1513532E (pt) 2007-05-31
CA2488915C (en) 2011-10-04
NZ537180A (en) 2008-03-28
EP2298302A1 (en) 2011-03-23
WO2003103673A1 (en) 2003-12-18
IL165517A0 (en) 2006-01-15
ATE355061T1 (de) 2006-03-15
AU2003251482A1 (en) 2003-12-22
SI1513532T1 (sl) 2007-08-31
UA82194C2 (uk) 2008-03-25
JP2014088422A (ja) 2014-05-15
CN101455649A (zh) 2009-06-17
MXPA04012333A (es) 2005-02-25
CN1658878A (zh) 2005-08-24

Similar Documents

Publication Publication Date Title
DK1513532T3 (da) Bortskaffelsessystemer til transdermale administrationsanordninger for at hindre misbrug af de aktive stoffer, der er indeholdt deri
DE60331552D1 (de) Darreichungssysteme von wirkstoffen mit poly(ethylene-co(meth)akrylate, medizinische vorrichtung und verfahren
NO982764L (no) Oppfinnelse og anordning for transdermal anordning for avgivelse av flurbiprofen
WO2006041911A3 (en) Device transdermal administration of drugs including acrylic polymers
WO2004039427A3 (en) Transdermal delivery system for anti-emetic medication
DK1542740T3 (da) Fluorpolymercoatinger til implanterbare, medicinske anordninger
DE60316579D1 (de) System zur abgabe von wirkstoffen mit einem hydrophoben cellulose-derivat
FR2791689B1 (fr) Microparticules reticulees, leur procede de preparation et applications
WO2006055429A3 (en) Method and apparatus for dynamically activating/deactivating an operating system
DE602005019891D1 (de) Polymere von fluormonomeren und hydrophilen monomeren
WO2003096726A3 (en) Method and apparatus for use in securing an electronic device such as a cell phone
CA2806183A1 (en) Transdermal adhesive compositions, devices, and methods
WO2006081210A3 (en) Medical device with drug release regions containing pseudo - block copolymers
WO2006083628A3 (en) Medical devices having polymeric regions with copolymers containing hydrocarbon and heteroatom-containing monomeric species
DK1957130T3 (da) Hydrofilt overtræk omfattende en polyelektrolyt
AU1728901A (en) Electropolymerizable monomers and polymeric coatings on implantable devices
WO2007080365A3 (en) Supported catalyst system
WO2006091774A3 (en) Transdermal electrotransport drug delivery systems with reduced abuse potential
WO2006039634A3 (en) Implantable medical devices containing phenolic compound
BR0013902A (pt) Composição de polìmero, dispositivo médico, e, métodos para o uso de que um cimento polimérico para a montagem de dispositivos médicos, e para montar um dispositivo médico usando técnicas de ligação com solvente
WO2009032266A3 (en) Dispersions of microparticles and microgels in hydrogels for drug delivery
WO2006049823A3 (en) Anti-thrombogenic and anti-restenotic vascular medical devices
AU8602201A (en) Complexing structure, device and method for treating liquid effluents
EP1434103A3 (en) Lithographic apparatus with alignment subsystem, device manufacturing method using alignment, and alignment structure
AU2003209929A8 (en) Electronic device, method, monomer and polymer